Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-029935
Filing Date
2004-02-26
Accepted
2004-02-26 11:50:04
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1331648
3 TERMINATION AND LICENSE AGREEMENT dex10201.htm EX-10.201 138329
4 LICENSE AGREEMENT dex10202.htm EX-10.202 163766
5 AMENDMENT NO 1 TO LICENSE AGREEMENT dex10203.htm EX-10.203 19380
6 COLLABORATION AGREEMENT dex10204.htm EX-10.204 499681
7 PHARMACEUTICAL PRODUCT DEVELOPMENT, INC., AND SUBSIDIARIES dex21.htm EX-21 28405
8 CONSENT OF INDEPENDENT AUDITORS dex231.htm EX-23.1 1709
9 CONSENT OF INDEPENDENT AUDITORS dex232.htm EX-23.2 1562
10 CERTIFICATION dex311.htm EX-31.1 9507
11 CERTIFICATION dex312.htm EX-31.2 9494
12 CERTIFICATION dex321.htm EX-32.1 3047
13 CERTIFICATION dex322.htm EX-32.2 3029
  Complete submission text file 0001193125-04-029935.txt   2212440
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 04629609
SIC: 8731 Services-Commercial Physical & Biological Research